Le Lézard
Classified in: Health
Subjects: CCA, PET, FVT

Heska First Quarter 2019 Results and Conference Call Scheduled for May 7, 2019


LOVELAND, Colo., April 16, 2019 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, plans to report its first quarter 2019 financial results in a press release on Tuesday, May 7, 2019 before the market opens and to host a conference call on the results at 9 a.m. MT / 11 a.m. ET on the same day.

Heska Corporation (PRNewsfoto/Heska Corporation)

To access the conference call:
From within the United States, please dial 1-800-263-0877
From outside of the United States, please dial 1-646-828-8143
Reference Conference ID: 7378088

The conference call will be webcast live from the Company's website on www.heska.com.

A telephonic replay will be available beginning at 2 p.m. ET and continue through 11:59 p.m. ET on Tuesday, May 14, 2019. The webcast will be archived on www.heska.com for 90 days.

To access the replay:
From within the United States, please dial 1-844-512-2921
From outside the United States, please dial 1-412-317-6671
Reference Replay Pin Number: 7378088

About Heska
Heska Corporation (NASDAQ: HSKA - News) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through two business segments; Core Companion Animal Health ("CCA") represents approximately 85% of revenues, and Other Vaccines, Pharmaceuticals and Products ("OVP") segment represents approximately 15% of revenues. CCA segment includes Point of Care Laboratory testing instruments and consumables, primarily under a unique multi-year Reset Subscription model, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. OVP segment includes private label vaccine and pharmaceutical production under third party agreements and channels, primarily for herd animal health. For further information on Heska and its products, visit www.heska.com.

 

 

SOURCE Heska Corporation


These press releases may also interest you

at 07:12
Chiesi Group's 2023 Revenue Surpasses ?3 Billion Mark, Reflecting 10% Growth Year-on-Year (+12% @CER), Underlining Commitment to Innovative, Sustainable Practices
Highlights from Chiesi Group's 2023 financial report: Sales increased to over ?3 billion, up 10% compared to 2022 (+12% @CER), driven by the Rare business unit growth (65% @CER), and steady growth of all products in all its Regions24% of 2023 sales...

at 07:05
Av?sis and Harmony Health Launch Pioneering Salivary Testing Pilot for Patients with Special Healthcare Needs
Av?sis and Harmony Health have joined forces to bridge oral healthcare gaps for underserved Medicaid populations with special healthcare needs. The pilot aims to revolutionize preventive dentistry by harnessing the power of real-time salivary testing...

at 07:05
United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024
United Therapeutics Corporation , announced today that it will report its first quarter 2024 financial results before the market opens on Wednesday, May 1, 2024. A press release detailing the quarterly results will be issued that day at approximately...

at 07:05
Innoviva Specialty Therapeutics' Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024
Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc. , today announced that positive results from the Phase 3 oral zoliflodacin trial will be highlighted in an oral presentation given by the Global Antibiotic Research & Development...

at 07:05
METRO Inc. to launch Moi Rewards in Ontario offering new ways to save
METRO Inc. will launch Moi Rewards in all 275 Metro and Food Basics stores in Ontario later this year. Moi Rewards will allow members to save on their grocery purchases by accumulating and redeeming points in-store and online, and to receive...

at 07:05
REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
REGENXBIO Inc. today announced it will participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit on Monday, April 29, 2024. Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit Fireside Chat:...

More news about Health...


News published on and distributed by: